Skip to main content
. 2023 Apr 14;12(8):1156. doi: 10.3390/cells12081156

Figure 5.

Figure 5

Roles of autophagy in cancer cells resistant to immunotherapy. Besides the activation of cytoprotective autophagy, cancer cells’ acquired immunotherapy resistance inhibits degradatory autophagy, thus increasing the amount of surface PD-L1 to interfere with the efficacy of immunotherapy. (HMGB1 = high mobility group box 1; PD-1 = programmed cell death protein 1; PD-L1 = programmed death-ligand 1; S1R = Sigma 1 receptor).